Clinical Profile and Intraocular Pressure Control of Medically Treated Glaucoma Patients Seen in a Tertiary Hospital in Enugu, Nigeria
Main Article Content
Abstract
Background: Glaucoma is the second most common cause of blindness and the leading cause of irreversible blindness worldwide. It is a chronic optic neuropathy with characteristic optic disc changes and corresponding visual field defect.
Aim: The aim of this study was to determine the clinical profile and intraocular pressure control of Primary Open Angle Glaucoma (POAG) patients on medical treatment at the glaucoma clinic of Enugu State University of Science and Technology Teaching Hospital Parklane (ESUTTHP), Enugu with a view for better patient management.
Methods: The study was a hospital based cross sectional study on POAG patients on medical treatment attending the eye clinic of ESUTTHP, Enugu. Patients were selected by simple random sampling. Their eyes were examined which included visual acuity assessment, follow-up clinic intraocular pressure measurement, gonioscopy, anterior and posterior segments examination. Water Drinking Test (WDT) and modified phasing were carried out on them. WDT was done over 2 hours after intake of 1 liter of water with intraocular pressure measured every 15 minutes. Modified phasing was done over 8 hours with intraocular pressure measured at 2 hourly intervals. Data analysis was done using SPSS version 20 (U.S.A). The mean follow-up clinic intraocular pressure (IOP), IOP peak and fluctuation during WDT and phasing were determined and compared using T-test.
Results: A total of 130 primary angle glaucoma patients on medical treatment were examined comprising of 43.1% males and 56.9% females with mean age of 62.25±9.002. Few of the patients were blind (3.8%) while 66.2% had normal vision. Their mean vertical cup disc ratio was 0.78±0.13. Majority of the patients had thin central cornea and uncontrolled intraocular pressure. The mean follow-up clinic IOP, mean IOP peaks during WDT and phasing were 16.2±4.3, 22.9±5.7, 18.0±4.4mmHg, respectively. There was a significant correlation between central corneal thickness and IOP peaks in WDT and modified phasing as well as follow-up clinic IOP but there was no significant correlation between central corneal thickness and IOP fluctuations in WDT and modified phasing. There was a significant correlation between vertical cup disc ratio and IOP peaks in WDT as well as vertical cup disc ratio and follow-up clinic IOP (p< 0.01).
Conclusion: Few patients are blind from glaucoma but greater percentage still have uncontrolled IOP despite being on medical treatment. Therefore, other treatment options should be explored to bring their IOP under control to avoid further glaucomatous progression and consequent blindness.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389–393.
II. Ntim-Amponsah CT, Amoaku WMK, Ofosu-Amaah S, Ewusi RK, Idirisuriya-Khair R, Nyatepe-Coo E, et al. Prevalence of glaucoma in an African population. Eye. 2004;18:491–497.
III. Olawoye O, Tarella S. Spectrum of Glaucoma Presentation in a Nigerian Tertiary Hospital. Niger J Ophthalmol. 2014;22:11–15.
IV. Achigbu EO, Chuka-Okosa CM, Achigbu KI. The knowledge, perception, and attitude of patients living with glaucoma and attending the eye clinic of a secondary health care facility in South-East, Nigeria. Niger J Ophthalmol. 2015;23:1–5.
V. Shaarawy T, Flammer J, Haefliger IO. Reducing intraocular pressure: is surgery better than drugs? Eye. 2004;18:1215–1224.
VI. Ancker E. Glaucoma Algorithm and Guidelines for Glaucoma Diagnosis and Management. [Internet]. Hatfield: South African Glaucoma Society; 2006. [cited 2015 Nov 4] 16 p. Available from www.icoph.org
VII. Leske CM, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for Glaucoma Progression and the Effect of Treatment-The Early Manifest Glaucoma Trial. Arch Ophthalmol. 2003;121:48–56.
VIII. De Moraes CG V, Juthani VJ, Liebmann JM, Teng CC, Tello C, Susanna Jr R, et al. Risk Factors for Visual Field Progression in Treated Glaucoma. Arch Ophthalmol. 2011;129:563–567.
IX. Otabil KB, Tenkorang SB, Mac AL, Otabil EA. Prevalence of glaucoma in an eye clinic in Ghana. Russ Open Med J. 2013;2:1–5.
X. Salomão SR, Mitsuhiro MRKH, Belfort R. Visual impairment and blindness: An overview of prevalence and causes in Brazil. Ann Brazilian Acad Sci. 2009;81:539–540.
XI. Leske MC, Connell AM, Schachat AP, Hyman L. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821–829.
XII. Rabiu M, Abdull MM, Kyari F, Abubakar T, Imam AU, Bankole O. The Nigeria national blindness and visual impairment survey 2005-2007. Investig Ophthalmol Vis Sci. 2009;50:4114–4120.
XIII. Racette L, Wilson MR, Zangwill LM, Weinreb RN, Sample PA. Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol. 2003;48:295–313.
XIV. Nosiri C, Chawat S, Abba G. Prevalence Of Glaucoma In Nigeria. Internet J Epidemiol. 2009;9:1–5.
XV. Foster PJ, Johnson GJ. Glaucoma in China: how big is the problem? Br J Ophthalmol. 2001;85:1277–1282.
XVI. Rota-Bartelink AM, Pitt A, Stoty I. Influence of Diurnal Variation on the Intraocular Pressure Measurement of Treated Primary Open Angle Glaucoma during office hours. J Glaucoma. 1996;4:410–415.
XVII. Drance SM. Diurnal Variation of Intraocular Pressure in Treated Glaucoma-Significance in Patients With Chronic Simple Glaucoma. Arch Ophthalmol. 1963;70:302–311.
XVIII. Clement C, Bhartiya S. IOP assessment with the water drinking test [Internet]. Glaucoma Now. 2013 [cited 2015 Dec 5]. p. 10–1. Available from: www.glaucomanow.com
XIX. Varma R, Hwang L-J, Grunden JW, Bean GW. Inter-visit intraocular pressure range: an alternative parameter for assessing intraocular pressure control in clinical trials. Am J Ophthalmol. 2008;145:336–342.
XX. Susanna Jr R, Hatanaka M, Vessani RM, Pinheiro A, Morita C. Correlation of Asymmetric Glaucomatous Visual Field Damage and Water-Drinking Test Response. Investig Ophthalmol Vis Sci. 2006;47:641–644.
XXI. Browling B. Kanski’s Clinical Ophthalmology. A systematic Approach. Eight edit. China: Elsevier limited; 2016. Chapter 10, Glaucoma; 305-395 p.
XXII. Vasconcelos-Moraes CG, Susanna Jr R. Correlation between the water drinking test and modified diurnal tension curve in untreated glaucomatous eyes. Clinics. 2008;63:433–436.
XXIII. Caiado RR, Badaró E, Kasahara N. Intraocular pressure fluctuation in healthy and glaucomatous eyes: a comparative analysis between diurnal curves in supine and sitting positions and the water drinking test. Arq Bras Oftalmol. 2014;77:288–292.
XXIV. Medeiros FA, Pinheiro A, Moura FC, Leal BC, Susanna Jr R. Intraocular Pressure Fluctuations in Medical versus Surgically Treated Glaucomatous Patients. J Ocul Pharmacol Ther. 2002;18:489–498.
XXV. Gachago MM. Knowledge, attitudes and practices of glaucoma patients attending clinic at Kenyatta National hospital. Master's (dissertation). Nairobi. University of Nairobi; 2011. 10-65 p.
XXVI. Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in Northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmology; 2015;15:111.
XXVII. Olajide O, Onabolu O, Jagun O, Betiku A, Alao G, Aham-onyebuchi U, et al. Spectrum of Glaucoma Presentation in a Suburban Teaching Hospital in South Western Nigeria. Heal Sci J Sci J. 2016;10:1–4.
XXVIII. De Moraes CG V, Furlanetto LR, Reis ASC, Vegini F, Cavalcanti FN, Susanna Jr R. Agreement between stress intraocular pressure and long-term intraocular pressure measurements in primary open angle glaucoma. Clin Exp Ophthalmol. 2009;37:270–274.
XXIX. Moodie J, Wilde C, Rotchford AP, Vernon SA, King AJ. 24-Hour versus daytime intraocular pressure phasing in the management of patients with treated glaucoma. Br J Ophthalmol. 2010;94:999–1002.
XXX. Arora T, Jindal S, Arora V, Wadhwani M. Diurnal versus office-hour intraocular pressure. J Optom. Spanish General Council of Optometry; 2015;8:239–243.
XXXI. Hughes E, Spry P, Diamond J. 24-hour monitoring of intraocular pressure in glaucoma management: a retrospective review. J Glaucoma. 2003;12:232–236.
XXXII. Onakoya A, Mbadugha C. Self-reported adherence rates in glaucoma patients in Southwest Nigeria. J Clin Sci. 2016;13:51–57.
XXXIII. Vetrugno M, Sisto D, Trabucco T, Balducci F, Noci ND, Sborgia C. Water-Drinking Test in Patients with Primary Open-Angle Glaucoma While Treated with Different Topical Medications. J Ocul Pharmacol Ther. Journal of Ocular Therapy; 2005;21:250–257.
XXXIV. Mansouri K, Medeiros FA, Weinreb RN. Effect of Glaucoma Medications on 24-hour Intraocular Pressure-related Patterns Using a Contact Lens Sensor. Clin Exp Ophthalmol. 2015;43:787–795.
XXXV. Furlanetto RL, Facio AC, Hatanaka M, Susanna Junior R. Correlation between central corneal thickness and intraocular pressure peak and fluctuation during the water drinking test in glaucoma patients. Clinics. 2010;65:967–970.